Molecular Diagnostics Market to exceed US$ 20 Billion by 2024

“Global Molecular Diagnostics Market is projected to become US$ 20.5 Billion opportunities by the year 2024.”
Renub Research report titled “Molecular Diagnostics Market, Global Forecast by Application (Infectious Diseases, Blood Screening, Oncology, Genetic Testing, HLA, Microbiology, Cardiovascular Diseases, Neurological Diseases & Others), By Technology (PCR, TMA, Hybridiazation, DNA Sequencing & NGS, Microarray & Others), By End User (Hospitals & Academic Laboratories, Clinics & Commercial Laboratories, Others), By Regions, Companies” provides a complete analysis of Molecular Diagnostics Market.

Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.

Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)

Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.

 

Request a free sample copy of the report: https://www.renub.com/contactus.php

Molecular Diagnostics for Infectious Disease

Over the last several years, the expansion and application of molecular diagnostic techniques has spurred a revolution in the field of disease diagnosis and monitoring, especially for infectious diseases. Microbial phenotypic characteristics, such as bacteriophage, protein and chromatographic profiles, as well as susceptibility testing and biotyping, are used wide openly in today’s everyday laboratories for identification and differentiation. Nucleic acid techniques, such as various methods for generating restriction fragment length polymorphisms, plasmid profiling, and the polymerase chain reaction (PCR), are making increasing incursion into clinical laboratories. A PCR-based system helps to detect the etiology of the disease straight from the clinical samples without the need for culture and have been significantly useful in the rapid detection of un-culturable or fastidious microbes. In addition; sequence analysis of amplified microbial DNA allows for better characterization and identification of the pathogen.

             

Further, molecular diagnostics have also paved the roads for the microbiologists who now searched for go for more rapid and efficient means of microbial identification. The identification and differentiation of microbes have basically relied on the microbial growth variables and their morphology. Advancement in the molecular diagnostics has opened new possibilities for microbial identification and characterization.

 

Client can Purchase this Report in Sections from below link:

Access full Research: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php

Molecular Diagnostics Market is exploding very rapidly in the past few years as it has proven readily versatile for use in the clinical laboratory and promise to be exceptionally useful in the diagnosis, therapy, and epidemiologic investigations of various diseases and their control; it is believed that the molecular diagnostics market will keep flourishing in the coming years. Also, rapid detection and tests accuracy are believed to drive demand for molecular diagnostic tests for infectious disease.

 

Browse Related Reports :

China IVD Market

China Molecular Diagnostics Market

 

 

Contact Us

Renub Research

Phone:+1-678-302-0700

Email: info@renub.com

 

Key Topics Covered :

1. Executive Summary

2. Global Molecular Diagnostic Market

3. Market Share – Global Molecular Diagnostics

3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies

4. Application – Molecular Diagnostics Market

4.1 Infectious Diseases
4.2 Blood Screening
4.3 Oncology / Cancer
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others

5. Technology – Molecular Diagnostics Market

5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others

6. Region – Molecular Diagnostics Market

6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)

7. End Users – Molecular Diagnostics Market

7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others

8. Roche Diagnostics – Company Analysis

8.1 Merger & Acquisitions
8.2 Sales Analysis

9. Abbott Laboratories – Company Analysis

9.1 Merger & Acquisitions
9.2 Sales Analysis

10. Myriad Genetics – Company Analysis

10.1 Merger & Acquisitions
10.2 Sales Analysis

11. Qiagen – Company Analysis

11.1 Merger & Acquisitions
11.2 Sales Analysis

12. BioMérieux’s Inc – Company Analysis

12.1 Merger & Acquisitions
12.2 Sales Analysis

13. Market Drivers

13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety

14. Challenges

14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance

 

 

About Us

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Media Contact
Company Name: Renub Research
Contact Person: Rajat Gupta
Email: Send Email
Phone: 6783020700
Address:225 Kristie Ln
City: Roswell
State: GA
Country: United States
Website: www.renub.com/diagnostics-14-c.php